Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10098725rdf:typepubmed:Citationlld:pubmed
pubmed-article:10098725lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:10098725lifeskim:mentionsumls-concept:C0041249lld:lifeskim
pubmed-article:10098725lifeskim:mentionsumls-concept:C0132555lld:lifeskim
pubmed-article:10098725lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:10098725lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:10098725lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:10098725lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:10098725lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:10098725lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:10098725lifeskim:mentionsumls-concept:C0337184lld:lifeskim
pubmed-article:10098725lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:10098725pubmed:issue6lld:pubmed
pubmed-article:10098725pubmed:dateCreated1999-5-6lld:pubmed
pubmed-article:10098725pubmed:abstractTextIncreases in the brain concentrations of tryptophan and in serotonin (5-HT) metabolism are commonly observed in animals under stress. Previous experiments indicated that the increase in brain tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) observed in response to administration of endotoxin (lipopolysaccharide, LPS) and interleukin-1 (IL-1) were largely prevented by pretreatment with N-nitro-L-arginine methylester (L-NAME), an inhibitor of NO synthase (NOS). Therefore we tested whether the increases in tryptophan and 5-HT metabolism observed following restraint and footsthock were similarly affected. Mice were injected with L-NAME (30 mg/kg) or saline and restrained for 40 min. Restraint caused increases in concentrations of tryptophan and the catabolites of dopamine (DA), norepinephrine (NE) and 5-HT in the medial prefrontal cortex, hypothalamus, and brain stem. The L-NAME pretreatment significantly attenuated, but did not prevent, the changes in tryptophan and catecholamine metabolism, with a very small effect on the increase in plasma corticosterone. When mice pretreated with L-NAME were subjected to 30 min footshock, the NOS inhibitor had no statistically significant effects on the increases in DA, NE and 5-HT metabolism, but tended to attenuate the increases in tryptophan. We interpret these results to indicate that NOS plays a relatively small role in the cerebral neurochemical responses to restraint and footshock, but the role in the restraint-induced changes was greater than that in the footshock-induced ones. The attenuation of the restraint-related effects on the catecholamines most probably reflects a contribution to the CNS responses from peripheral vascular changes which are likely to be limited by the inhibition of NOS.lld:pubmed
pubmed-article:10098725pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10098725pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10098725pubmed:languageenglld:pubmed
pubmed-article:10098725pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10098725pubmed:citationSubsetIMlld:pubmed
pubmed-article:10098725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10098725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10098725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10098725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10098725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10098725pubmed:statusMEDLINElld:pubmed
pubmed-article:10098725pubmed:monthDeclld:pubmed
pubmed-article:10098725pubmed:issn0197-0186lld:pubmed
pubmed-article:10098725pubmed:authorpubmed-author:DunnA JAJlld:pubmed
pubmed-article:10098725pubmed:issnTypePrintlld:pubmed
pubmed-article:10098725pubmed:volume33lld:pubmed
pubmed-article:10098725pubmed:ownerNLMlld:pubmed
pubmed-article:10098725pubmed:authorsCompleteYlld:pubmed
pubmed-article:10098725pubmed:pagination551-7lld:pubmed
pubmed-article:10098725pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:10098725pubmed:meshHeadingpubmed-meshheading:10098725...lld:pubmed
pubmed-article:10098725pubmed:meshHeadingpubmed-meshheading:10098725...lld:pubmed
pubmed-article:10098725pubmed:meshHeadingpubmed-meshheading:10098725...lld:pubmed
pubmed-article:10098725pubmed:meshHeadingpubmed-meshheading:10098725...lld:pubmed
pubmed-article:10098725pubmed:meshHeadingpubmed-meshheading:10098725...lld:pubmed
pubmed-article:10098725pubmed:meshHeadingpubmed-meshheading:10098725...lld:pubmed
pubmed-article:10098725pubmed:meshHeadingpubmed-meshheading:10098725...lld:pubmed
pubmed-article:10098725pubmed:meshHeadingpubmed-meshheading:10098725...lld:pubmed
pubmed-article:10098725pubmed:meshHeadingpubmed-meshheading:10098725...lld:pubmed
pubmed-article:10098725pubmed:meshHeadingpubmed-meshheading:10098725...lld:pubmed
pubmed-article:10098725pubmed:meshHeadingpubmed-meshheading:10098725...lld:pubmed
pubmed-article:10098725pubmed:year1998lld:pubmed
pubmed-article:10098725pubmed:articleTitleBrain catecholaminergic and tryptophan responses to restraint are attenuated by nitric oxide synthase inhibition.lld:pubmed
pubmed-article:10098725pubmed:affiliationDepartment of Pharmacology and Therapeutics, Louisiana State University Medical Center, Shreveport 71130, USA. adunn@lsumc.edulld:pubmed
pubmed-article:10098725pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10098725pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10098725lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10098725lld:pubmed